pLVX-IRES Hyg SMAD4 Citations (2)

Originally described in: TGF-beta Tumor Suppression through a Lethal EMT.
David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massague J Cell. 2016 Feb 25;164(5):1015-30. doi: 10.1016/j.cell.2016.01.009. Epub 2016 Feb 18. PubMed Journal

---

Articles Citing pLVX-IRES Hyg SMAD4

Articles
NF1 loss of function as an alternative initiating event in pancreatic ductal adenocarcinoma. Ramakrishnan G, Parajuli P, Singh P, Friend C, Hurwitz E, Prunier C, Razzaque MS, Xu K, Atfi A. Cell Rep. 2022 Nov 8;41(6):111623. doi: 10.1016/j.celrep.2022.111623. PubMed
ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. Lee DKC, Chen K, Loke R, Li X, Liubart D, Saffi GT, Chow JTS, Melo CMP, To L, Salmena L. Mol Oncol. 2025 Nov;19(11):3342-3359. doi: 10.1002/1878-0261.70080. Epub 2025 Jul 30. PubMed

If you have published an article using this material, please email us at to have your article added to this page.